Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
17.28
Price to sales ratio
3.03

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
129
SYK
Stryker Corporation Common Stock
309.55 USD-0.86%-5.70%-8.86%-20.30%118.74 B USD
133
MDT
Medtronic plc. Ordinary Shares
92.45 USD+0.26%+1.07%+8.19%-1.47%118.34 B USD
307
EW
Edwards Lifesciences Corporation Common Stock
89.92 USD-0.96%-1.48%+1.63%+10.29%51.83 B USD
334
MDLN
Medline Inc. - Class A common stock
36.44 USD+0.39%+4.44%-10.09%+4.11%47.91 B USD

Frequently asked questions about Boston Scientific Corp.

What is the Boston Scientific Corp. stock price today?

The current price of Boston Scientific Corp. (BSX) is 47.16. Over the past 24 hours, the stock has changed by -2.52%. Follow the BSX chart for real-time price dynamics.

What is the stock ticker of Boston Scientific Corp.?

Boston Scientific Corp. trades under the ticker BSX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Boston Scientific Corp. stock going up?

BSX has changed by -0.46% over the last week, -2.44% over the last month, and -56.17% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Boston Scientific Corp.?

Boston Scientific Corp. currently has a market capitalization of 68.35 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Boston Scientific Corp. earnings last quarter?

Last quarter, Boston Scientific Corp. reported earnings of 0.62 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Boston Scientific Corp. revenue for the last quarter?

Boston Scientific Corp. reported quarterly revenue of 5.44 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Boston Scientific Corp. net income for the last quarter?

Boston Scientific Corp. reported net income of 905 M for the last quarter. The previous quarter showed 1.34 B, which means net income changed by -32.41%.

How many employees does Boston Scientific Corp. have?

As of the latest available data, Boston Scientific Corp. has 59 K employees. Workforce size can provide additional context about the company's scale and operations.

What is Boston Scientific Corp. EBITDA?

Boston Scientific Corp. EBITDA is 1.53 B, and its EBITDA margin is 28.17%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Boston Scientific Corp. stock?

You can buy Boston Scientific Corp. (BSX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Boston Scientific Corp. stock?

Investing in Boston Scientific Corp. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BSX chart and related analysis on metatrader.com as part of your research.

Boston Scientific Corporation Common Stock

Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware.

News